FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

25321611000001107: Ranicalm 75mg tablets (Bristol Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Aug 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80523901000001115 Ranicalm 75mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80524001000001117 Ranicalm 75mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 75 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Is a Ranicalm true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ranicalm 75mg tablets (Bristol Laboratories Ltd) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ranicalm 75mg tablets (Bristol Laboratories Ltd) 12 tablet Has AMP True Ranicalm 75mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start